MYO1D and breast cancer: After knocking down MYO1D, the protein levels of N-cad and vimentin were reduced in MDA-MB-231 and BT-549 cells, which inhibited EMT (epithelial cell-to-mesenchymal transition) in breast cancer cells in comparison to the control group (Fig. 7E).